Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit.
Twenty patients in the intensive care unit received an infusion of atracurium to permit mechanical ventilation. The duration of infusion ranged from 38 to 219 h and the average rate of infusion during the study was 0.76 mg kg-1 h-1. In 14 patients an increase in atracurium requirement occurred within the first 72 h of the infusion. Recovery from neuromuscular blockade after a prolonged infusion was sufficiently rapid to avoid pharmacologically induced reversal. In six patients maximum plasma concentrations of laudanosine were 1.9-5 micrograms ml-1, and there was no evidence of cerebral excitation.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001279:Atracurium / Q000008:administration & dosage*; D002648:Child; D003422:Critical Care; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007385:Intermittent Positive-Pressure Ventilation; D007546:Isoquinolines / Q000097:blood*; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D007546:Isoquinolines; D001279:Atracurium; C001522:laudanosine